SEC Form 4 · accession 0001209191-15-060634
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey T. Walsh
Officer — Chief Operating Officer
Period of report
Jul 10, 2015
Accepted (ET)
Jul 13, 2015 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2015 | M | 11,000 | $2.09 | A | 11,000 | D | |
| Common StockF2 | Jul 10, 2015 | S | 3,770 | $157.4007 | D | 7,230 | D | |
| Common StockF3 | Jul 10, 2015 | S | 3,532 | $158.4333 | D | 3,698 | D | |
| Common StockF4 | Jul 10, 2015 | S | 2,100 | $159.4198 | D | 1,598 | D | |
| Common StockF5 | Jul 10, 2015 | S | 600 | $160.215 | D | 998 | D | |
| Common StockF6 | Jul 10, 2015 | S | 900 | $161.2779 | D | 98 | D | |
| Common StokF7 | Jul 10, 2015 | S | 98 | $162.1862 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F8 | $2.09 | Jul 10, 2015 | M | 11,000 | D | — | Jul 13, 2021 | Common Stock | 11,000 | 51,513 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 26, 2014.
- F2The range of prices for the transaction reported on this line was $157.05 to $157.76. The average weighted price was $157.4007. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $158.01 to $158.95. The average weighted price was $158.4333. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $159.02 to $159.99. The average weighted price was $159.4198. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $160.13 to $160.36. The average weighted price was $160.2150. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $161.01 to $161.575. The average weighted price was $161.2779. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range of prices for the transaction reported on this line was $162.18 to $162.34. The average weighted price was $162.1862. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 16, 2012 and in 36 equal monthly installments thereafter.